Induction of apoptosis by α1-adrenoceptor antagonists in benign prostatic hyperplasia and prostate cancer [PDF]
, 2000 Natasha Kyprianou
openalex +1 more source
Effects of a new steroidal aromatase inhibitor, TZA-2237, and/or chlormadinone acetate on hormone-induced and spontaneous canine benign prostatic hyperplasia [PDF]
, 2000 Koki Ito +7 more
openalex +1 more source
Urology Journal, 2009 The failure of prostate-directed treatment modalities to help all men or all symptoms has questioned the longstanding assumption that the prostate is at the root of all male urinary symptoms, and a correlation between urinary bladder function and ...
Konstantinos Stamatiou
doaj
The correlation between clinical outcome and residual prostatic weight ratio after transurethral resection of the prostate for benign prostatic hyperplasia [PDF]
, 2000 Shengmei Chen +3 more
openalex +1 more source
Single dose methodology to assess the influence of an α1‐adrenoceptor antagonist on uroflowmetric parameters in patients with benign prostatic hyperplasia [PDF]
, 2000 Sean Curtis +6 more
openalex +1 more source
The role of inflammatory mediators in the development of prostatic hyperplasia and prostate cancer
Research and Reports in Urology, 2012 Johny E Elkahwaji1–31Section of Urologic Surgery, 2Section of Medical Oncology and Hematology, 3Genitourinary Oncology Research Laboratory, University of Nebraska Medical Center, Omaha, NE, USAAbstract: Benign prostatic hyperplasia and prostate
Elkahwaji JE
doaj
Effect of circadian rhythm disruption on benign prostatic hyperplasia in rats. [PDF]
PeerJHuang X, Tang X, Xu Y, Liu Z, Luo G.
europepmc +1 more source
Benign prostatic hyperplasia. [PDF]
Quality and Safety in Health Care, 1996 A, Melville +3 more
openaire +2 more sources
Management and Treatment of Benign Prostatic Hyperplasia Symptoms: Current Insights. [PDF]
Res Rep UrolZekraoui O +4 more
europepmc +1 more source